rational
pneumocysti
jirovecii
caus
sever
pneumonia
immunocompromis
host
human
immunodefici
viru
infect
malign
solid
organ
hematopoiet
cell
transplant
primari
immun
defici
compos
risk
factor
pneumocysti
pneumonia
pcp
children
pcp
initi
clinic
manifest
primari
immun
defici
patient
concern
infant
present
cyanosi
tachypnea
previou
medic
birth
histori
suggest
primari
immun
defici
diagnos
interstiti
pneumonia
admiss
diagnos
diagnos
pcp
evalu
reveal
underli
xlink
hyperigm
syndrom
intervent
treat
trimethoprimsulfamethoxazol
pcp
eventu
receiv
allogen
hematopoiet
cell
transplant
hyperigm
syndrom
outcom
twenti
month
pass
transplant
without
sever
complic
lesson
pcp
consid
infant
present
sever
interstiti
pneumonia
even
absenc
evid
immun
defici
primari
immun
defici
also
suspect
infant
diagnos
pcp
abbrevi
hd
hospit
day
higm
hyperigm
hiv
human
immunodefici
viru
pcp
pneumocysti
pneumonia
pcr
polymeras
chain
reaction
pid
primari
immun
defici
tmpsmx
trimethoprimsulfamethoxazol
children
pneumocysti
pneumonia
pcp
mostli
report
epidem
prematur
malnourish
infant
case
pcp
develop
children
immunocompromis
state
patient
infect
human
immunodefici
viru
hiv
compris
major
patient
pcp
sinc
accordingli
suspicion
diagnosi
pcp
children
without
evid
underli
immunocompromis
state
easi
primari
immun
defici
pid
well
hiv
infect
malign
transplant
known
risk
factor
pcp
pcp
initi
clinic
manifest
pid
diagnos
male
infant
present
cyanosi
interstiti
pneumonia
pcp
although
previou
histori
consist
pid
evalu
reveal
xlink
hyperigm
higm
syndrom
receiv
hematopoiet
cell
transplant
underli
higm
syndrom
case
report
approv
institut
review
board
seoul
st
mari
hospit
approv
written
inform
consent
public
obtain
patient
parent
male
infant
present
cyanosi
mother
diagnos
rheumatoid
arthriti
month
birth
pregnanc
identifi
gestat
age
month
medic
therapi
rheumatoid
arthriti
discontinu
sinc
mother
experienc
improv
symptom
rheumatoid
arthriti
without
medic
patient
born
via
caesarean
section
gestat
age
week
birth
weight
kg
exhibit
medic
problem
birth
two
week
prior
fever
vomit
diarrhea
develop
treat
acut
gastroenter
primari
clinic
howev
visit
emerg
room
pediatr
outpati
clinic
hospit
persist
vomit
diarrhea
day
respect
vomit
diarrhea
continu
sinc
moreov
peripher
central
cyanosi
accompani
admiss
afebril
exhibit
respiratori
symptom
includ
cough
rhinorrhea
sputum
puls
oxymetri
show
spo
room
air
rose
oxygen
suppli
lmin
vital
sign
follow
heart
rate
beatsmin
respiratori
rate
breathsmin
bodi
temperatur
physic
examin
reveal
accessori
breath
sound
chest
auscult
chest
wall
retract
despit
tachypnea
chest
xray
show
bilater
diffus
hazi
without
definit
cardiomegali
fig
echocardiographi
reveal
eject
fraction
without
anatom
function
abnorm
blood
test
reveal
white
blood
cell
count
hemoglobin
level
gdl
platelet
count
creactiv
protein
level
mgdl
without
abnorm
find
blood
chemistri
suspect
interstiti
lung
diseas
noninfecti
caus
afebril
viral
pneumon
multiplex
polymeras
chain
reaction
pcr
test
respiratori
virus
perform
use
nasopharyng
swab
although
famili
individu
histori
consist
pid
pcr
test
pneumocysti
jirovecii
also
perform
use
nasal
swab
consid
interstiti
pneumon
accompani
sever
hypoxemia
without
accessori
breath
sound
admiss
respiratori
rate
increas
breathsmin
mechan
ventil
care
initi
hospit
day
hd
empir
intraven
trimethoprimsulfamethoxazol
tmpsmx
mgkg
tmp
thrice
day
treatment
possibl
pcp
also
initi
hd
methylprednisolon
mgkg
twice
day
also
administ
possibl
interstiti
pneumon
noninfecti
caus
chest
comput
tomographi
show
diffus
homogen
opac
occupi
alveolar
space
throughout
whole
lung
field
fig
multiplex
pcr
test
respiratori
virus
reveal
neg
result
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
adenoviru
human
metapneumoviru
rhinoviru
coronaviru
human
bocaviru
bronchoscopi
perform
hd
howev
find
definit
airway
inflamm
increas
pulmonari
secret
observ
result
pcr
test
p
jirovecii
perform
admiss
report
posit
even
hd
neg
cultur
result
bacteria
cytomegaloviru
mycobacterium
tuberculosi
report
bronchial
wash
fluid
sampl
cyst
p
jirovecii
observ
gomori
methenamin
silver
stain
bronchial
wash
fluid
wean
ventil
care
taper
methylprednisolon
dose
initi
hd
respect
chest
xray
find
show
improv
week
sinc
initi
treatment
fig
extub
hd
oxygen
suppli
methylprednisolon
treatment
complet
hd
respect
repeat
pcr
test
p
jirovecii
show
posit
result
week
initi
tmpsmx
treatment
pcr
test
show
neg
result
week
initi
treatment
tmpsmx
treatment
convert
prophylaxi
mgm
day
tmp
thrice
week
altern
day
hd
discharg
hospit
continu
tmpsmx
prophylaxi
hd
lymphocyt
subset
test
perform
hd
reveal
follow
result
cell
cell
cell
cell
cell
igg
mgdl
igm
mgdl
level
within
normal
limit
howev
iga
ige
level
could
measur
immunoglobulin
level
measur
month
admiss
show
similar
result
genet
studi
higm
syndrom
request
base
repeat
result
immunolog
test
one
month
discharg
novel
frameshift
mutat
exon
ligand
gene
identifi
use
gene
sequenc
ident
mutat
identifi
mother
heterozygot
patient
eventu
diagnos
xlink
higm
syndrom
tmp
smx
prophylaxi
intraven
immunoglobulin
replac
therapi
everi
week
continu
underw
unrel
match
peripher
blood
stem
cell
transplant
month
diagnosi
pcp
month
pass
transplant
without
sever
complic
case
pcp
infanc
report
epidem
prematur
malnourish
infant
around
time
world
war
ii
develop
countri
pcp
occur
sporad
immunocompromis
children
rather
epidem
infant
hiv
infect
regard
import
risk
factor
pcp
howev
immunocompromis
patient
hivneg
recent
occupi
greater
proport
patient
pcp
patient
hiv
infect
although
immunocompromis
children
hivneg
hematolog
malign
solid
tumor
hematopoiet
cell
solidorgan
transplant
recipi
children
pid
also
risk
pcp
cell
play
essenti
role
host
immun
defens
p
jirovecii
infect
therefor
cell
impair
rather
b
cell
phagocyt
impair
thought
risk
factor
pcp
among
children
pid
sever
combin
immun
defici
wiskottaldrich
syndrom
higm
syndrom
common
pid
among
children
pcp
higm
syndrom
caus
defect
signal
pathway
caus
limit
immunoglobulin
isotyp
switch
b
cell
therefor
normal
elev
igm
level
low
igg
iga
ige
level
observ
patient
show
normal
igg
level
thought
due
matern
antibodi
transfer
across
placenta
normal
igm
level
undetect
iga
ige
level
increas
proport
cell
rais
suspicion
higm
syndrom
higm
syndrom
manifest
cell
dysfunct
rather
b
cell
dysfunct
despit
hypogammaglobulinemia
case
caus
mutat
wwwmdjournalcom
gene
locat
x
chromosom
encod
cell
surfac
therefor
xlink
higm
syndrom
frequent
form
higm
syndrom
howev
sever
gene
mutat
involv
signal
pathway
dna
repair
system
immunoglobulin
isotyp
switch
caus
higm
syndrom
name
activationinduc
cytidin
deaminas
aicda
uracildna
glycosylas
ung
phosphatidylinositol
catalyt
delta
phosphatidylinositol
regulatori
subunit
alpha
nuclear
factorkappab
essenti
modul
nemoikkg
inhibitor
kappa
light
chain
gene
enhanc
b
cell
alpha
ikba
nuclear
factor
kappab
subunit
gene
particip
signal
pathway
post
meiotic
segreg
increas
mut
homolog
mut
homolog
ataxia
telangiectasia
mutat
atm
nibrinnijmegen
breakag
syndrom
gene
involv
dna
repair
system
form
mutat
express
autosom
recess
inherit
although
autosom
domin
inherit
also
report
therefor
genet
evalu
perform
patient
higm
syndrom
phenotyp
verifi
exact
diseas
mechan
perform
accur
genet
counsel
tradit
therapi
higm
syndrom
includ
immunoglobulin
replac
therapi
antibiot
prophylaxi
p
jirovecii
infect
hygien
measur
prevent
infect
care
monitor
complic
therapi
median
surviv
rate
diagnosi
higm
syndrom
report
year
howev
hematopoiet
cell
transplant
hct
perform
patient
higm
syndrom
improv
prognos
sinc
although
overal
surviv
rate
significantli
improv
patient
undergo
hct
compar
receiv
tradit
therapi
transplant
outcom
overal
surviv
rate
tend
improv
sinc
mitsuisekinaka
et
al
report
significantli
higher
overal
surviv
patient
undergo
hct
sinc
undergo
hct
among
hct
recipi
children
age
year
younger
show
higher
surviv
age
year
older
consid
improv
hct
practic
support
care
hct
recipi
hct
regard
main
therapi
higm
syndrom
especi
young
children
children
higm
syndrom
experi
respiratori
tract
infect
p
jirovecii
common
respiratori
pathogen
especi
infant
diagnos
xlink
higm
syndrom
year
age
initi
present
pcp
primari
infect
p
jirovecii
occur
infanc
earli
childhood
children
acquir
antibodi
p
jirovecii
year
age
seem
experi
asymptomat
infect
respiratori
symptom
sign
show
signific
differ
children
test
posit
neg
p
jirovecii
diagnos
respiratori
tract
infect
except
frequenc
apnea
clinic
differenti
p
jirovecii
infect
respiratori
tract
infect
due
caus
difficult
particular
pcp
hardli
suspect
children
pneumonia
evid
underli
immunocompromis
state
howev
pediatrician
consid
pcp
initi
clinic
present
pid
therefor
pcp
suspect
infant
sever
interstiti
pneumonia
accompani
normal
breath
sound
common
viral
bacteri
pathogen
identifi
even
though
infant
may
show
evid
immun
defici
addit
underli
pid
evalu
infant
diagnos
pcp
use
recent
develop
molecular
genet
techniqu
conclus
report
infant
present
sever
interstiti
pneumonia
diagnos
pcp
initi
manifest
underli
higm
syndrom
pcp
consid
infant
present
sever
interstiti
pneumonia
even
absenc
evid
immun
defici
pid
also
suspect
infant
diagnos
pcp
correct
underli
immunocompromis
state
fundament
